- Home
- SELF vs VNRX Comparison
SELF vs VNRX Comparison
Compare SELF & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- VNRX
- Stock Information
- Founded
- SELF 1983
- VNRX N/A
- Country
- SELF United States
- VNRX United States
- Employees
- SELF N/A
- VNRX N/A
- Industry
- SELF Real Estate Investment Trusts
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SELF Real Estate
- VNRX Health Care
- Exchange
- SELF Nasdaq
- VNRX Nasdaq
- Market Cap
- SELF 57.3M
- VNRX 67.2M
- IPO Year
- SELF N/A
- VNRX N/A
- Fundamental
- Price
- SELF $5.19
- VNRX $0.64
- Analyst Decision
- SELF
- VNRX Strong Buy
- Analyst Count
- SELF 0
- VNRX 4
- Target Price
- SELF N/A
- VNRX $4.17
- AVG Volume (30 Days)
- SELF 20.0K
- VNRX 524.2K
- Earning Date
- SELF 11-08-2024
- VNRX 11-14-2024
- Dividend Yield
- SELF 5.58%
- VNRX N/A
- EPS Growth
- SELF 39.82
- VNRX N/A
- EPS
- SELF 0.28
- VNRX N/A
- Revenue
- SELF $12,319,724.00
- VNRX $1,285,827.00
- Revenue This Year
- SELF N/A
- VNRX $180.66
- Revenue Next Year
- SELF N/A
- VNRX $558.69
- P/E Ratio
- SELF $18.62
- VNRX N/A
- Revenue Growth
- SELF 0.38
- VNRX 97.50
- 52 Week Low
- SELF $4.01
- VNRX $0.43
- 52 Week High
- SELF $5.85
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- SELF 55.82
- VNRX 49.57
- Support Level
- SELF $5.07
- VNRX $0.57
- Resistance Level
- SELF $5.21
- VNRX $0.68
- Average True Range (ATR)
- SELF 0.12
- VNRX 0.08
- MACD
- SELF 0.00
- VNRX -0.00
- Stochastic Oscillator
- SELF 65.52
- VNRX 58.40
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.